Evidence map›Paper›PMID 31905036›Full record

ReviewCell cycle (Georgetown, Tex.)2020

Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Elena Campione, Caterina Lanna, Laura Diluvio, Maria Vittoria Cannizzaro, Sandro Grelli, Marco Galluzzo, Marina Talamonti, Margherita Annicchiarico-Petruzzelli, Mara Mancini, Gerry Melino and 5 more

Open access · greenAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Anti-Atopic Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Is Atopic Dermatitis Only a Skin Disease?International journal of molecular sciences · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Elena CampioneUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-7447-6798
Caterina LannaUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-3485-6275
Laura DiluvioUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Maria Vittoria CannizzaroUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-6805-1005
Sandro GrelliDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0003-1028-3203
Marco GalluzzoUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-3424-5175
Marina TalamontiUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0002-3070-4071
Margherita Annicchiarico-PetruzzelliBiochemistry Laboratory, Istituto Dermopatico Immacolata (IDI-IRCCS), Rome, Italy.
Mara ManciniBiochemistry Laboratory, Istituto Dermopatico Immacolata (IDI-IRCCS), Rome, Italy.ORCID 0000-0001-5173-4854
Gerry MelinoDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-9428-5972
Eleonora CandiDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-8332-4825
Gianfranco SchiavonePlastic Surgery and Regenerative Surgery Unit, Istituto Dermopatico Immacolata (IDI-IRCCS), Rome, Italy.
Ying WangCAS Key Laboratory of Tissue Microenvironment and Tumor, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Yufang ShiKey Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Luca BianchiUnit of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
University of Rome Tor Vergata · ITIstituto Dermopatico dell'Immacolata · ITChinese Academy of Sciences · CN

Funding

Medical Research Council
6 · The paper itself

Abstract

While the epidermis is the frontline defense against infections and indeed, it is a peripheral lymphoid organ, the same immunological mechanisms may initiate and sustain pathological conditions. Indeed, a deregulated action against exogenous pathogens could activate a T cell response in atopic dermatitis, hidradenitis suppurativa and vitiligo. Atopic dermatitis (AD) is a chronic inflammatory skin condition with a complex pathophysiology. Although T helper 2 immunity dysregulation is thought to be the main cause of AD etiopathogenesis, the triggering mechanism is not well understood, and the treatment is often difficult. As the AD, hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a dramatic impact on the quality of life of the affected patients. The exact pathophysiology of HS is still unclear, but many evidences report a follicular obstruction and subsequent inflammation with TNF-α, interleukin (IL)-1β, IL-10, and IL-17 involvement. Vitiligo is an autoimmune epidermal disorder which consists of melanocytes destruction and skin depigmentation. Melanocytes destruction is mainly due to their increased oxidative-stress sensitivity with a consequent activation of innate first and adaptative immunity (CD8

Indexed as

CD8-Positive T-LymphocytesCytokinesDermatitis, AtopicHidradenitis SuppurativaHumansInterleukin-10Interleukin-17Interleukin-1betaTumor Necrosis Factor-alphaVitiligoCytokinesIL10 protein, humanIL17A protein, humanIL1B protein, humanInterleukin-10Interleukin-17Interleukin-1betaTumor Necrosis Factor-alphaAtopic dermatitishidradenitis suppurativavitiligo

Identifiers

PMID31905036
PMCPMC7028161
OpenAlexW2997375780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.